Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 4, 2002, Pages 367-370

  Van der Planken, Marc G ^a   Schroyens, W ^a   Vertessen, F ^a   Michiels, J J ^a   Berneman, Z N ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Deep vein thrombosis; Factor VIII inhibitor; Hemophilia A; Recombinant activated factor VII; Severe inflammation

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 8 INHIBITOR; D DIMER; FIBRINOGEN; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADULT; ANTIBIOTIC THERAPY; ANUS; ARTICLE; BLEEDING; CASE REPORT; DEEP VEIN THROMBOSIS; DRUG INFUSION; ECHOGRAPHY; HEMOPHILIA A; HOSPITAL ADMISSION; HUMAN; IMMOBILIZATION; INFECTION; INFLAMMATION; LEG THROMBOSIS; MALE; PRIORITY JOURNAL; TRANSFUSION; ULCER;

ADULT; ANTI-BACTERIAL AGENTS; FACTOR VII; HEMOPHILIA A; HUMANS; IMMOBILIZATION; INFECTION; ISOANTIBODIES; MALE; RECOMBINANT PROTEINS; VENOUS THROMBOSIS;

EID: 0036592748     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200206000-00014     Document Type: Article

References (4)

1. Current therapeutic possibilities with recombinant factor VIIa
2. Acute myocardial infarction following administration of recombinant activated factor VII (NovoSeven) in a patient with haemophilia A and inhibitor
3. Prospective randomized trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery
4. Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures